IOV EAP: Expanded Access Program of AMTAGVI that is Out of Specification for Commercial Release

Grants and Contracts Details

StatusActive
Effective start/end date11/23/2511/23/27

Funding

  • Iovance Biotherapeutics Incorporated: $2.00